PATENT CLAIM ANALYSIS

Application Number: 16148647
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["546", "221000"]

Abstract:
The compound of the formula (I-1): wherein all the symbols have the same meanings as described in the specification, has two cyclic groups, particularly phenoxy groups at specific substitution positions and thus has high human S1P 2  antagonistic activity. The compound may therefore be used as a therapeutic agent for S1P 2 -mediated diseases such as diseases resulting from vascular constriction, fibrosis, and respiratory diseases.

Claim (Index 3):
The method according to  claim 1 , wherein the compound of formula (I-A) is 2-{4-[3-(4-fluorophenoxy)-5-{[(4-hydroxy-4-isobutyl-1-piperidinyl)carbonyl]amino}phenoxy]phenyl}-2-methylpropanoic acid or a salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.32143
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15089690', '14592100', '15784376', '14347178', '14780152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.79564600901404
- 35 USC 102 Novelty (BERT): 0.5658811733796201
- Combined Prediction Score: 0.7726695254505981
- Mean Citation Score: 379.053078
- Max Citation Score: 439.05518
- Similarity Product: 385.8964805822957

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test